These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26289215)

  • 21. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.
    Bochot A; Mashhour B; Puisieux F; Couvreur P; Fattal E
    J Drug Target; 1998; 6(4):309-13. PubMed ID: 9894698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precorneal factors influencing the ocular distribution of topically applied liposomal inulin.
    Lee VH; Takemoto KA; Iimoto DS
    Curr Eye Res; 1984 Apr; 3(4):585-91. PubMed ID: 6713957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
    Agarwal P; Scherer D; Günther B; Rupenthal ID
    Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina.
    Thareja A; Leigh T; Hakkarainen JJ; Hughes H; Alvarez-Lorenzo C; Fernandez-Trillo F; Blanch RJ; Ahmed Z
    Int J Pharm; 2024 Jul; 660():124305. PubMed ID: 38852749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of topical cyclosporine A and dissolvent on corneal epithelium permeability of fluorescein.
    Benítez del Castillo JM; Castillo A; Toledano N; Durán S; del Aguila C; Otero M; García-Sanchez J
    Doc Ophthalmol; 1995; 91(1):49-55. PubMed ID: 8861636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of ocular drug penetration.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J; Wang L; Gao C; Zhang L; Xia H
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
    Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
    Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limits on optimizing ocular drug delivery.
    Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
    J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
    Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
    Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective Retinal Penetration of Lipophilic and Lipid-Conjugated Hydrophilic Agents Delivered by Engineered Liposomes.
    Lee J; Goh U; Lee HJ; Kim J; Jeong M; Park JH
    Mol Pharm; 2017 Feb; 14(2):423-430. PubMed ID: 27936751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
    Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
    Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes.
    Katahira N; Murakami T; Kugai S; Yata N; Takano M
    J Drug Target; 1999; 6(6):405-14. PubMed ID: 10937286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of liposomes on permeability of various compounds through rabbit corneas.
    Morimoto K; Nakamura T; Nakai T; Morisaka K
    Arch Int Pharmacodyn Ther; 1988; 293():7-13. PubMed ID: 3138953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.